
Number of publications published per year by Poelstra, Klaas. (Source : PubMed)

Distribution of publications types for Poelstra, Klaas. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor.
Int. J. Cancer
2010;126;8

Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.
Hepatology
2010;51;3
Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo.
Neoplasia
2009;11;12
Role of alkaline phosphatase in colitis in man and rats.
Gut
2009;58;3
Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis.
Pharm. Res.
2008;25;10
Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
Pharm. Res.
2007;24;3
Addressing liver fibrosis with liposomes targeted to hepatic stellate cells.
J Liposome Res
2007;17;3-4
Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes.
J Drug Target
2007;15;1
Targeting of the VEGF-kinase inhibitor PTK787 to angiogenic vasculature using RGD-equipped albumin carrier molecules.
J Control Release
2006;116;2
Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.
ChemMedChem
2006;1;11
[ See timeline ] [ See all publications ]
means that Poelstra, Klaas has 18 papers cited a least 18 times - methodology
Department of Pharmacokinetics and Drug Delivery, University Centre for Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.